Alkermes Plc
ALKS
Delayed Nasdaq - 05/25 10:00:00 pm
45.77USD
+0.77%
Upcoming events on ALKERMES PLC
08/02/18 Interim 2018 Earnings Release (Projected)
10/31/18 Q3 2018 Earnings Release (Projected)
Past events on ALKERMES PLC
05/23/18 | 01:00pmAnnual General Meeting
05/21/18 | 08:00pmUBS Global Healthcare and Life Sciences Conference
05/16/18 | 08:20pmBank of America Merrill Lynch Health Care Conference
05/10/18 | 02:30pmALKS 3831 Update Call
Upcoming sector events for ALKERMES PLC
05/30/18 | 05:00pm SAGE THERAPEUTICS INC : Bernstein Strategic Decisions CEO Conference
05/31/18 | 03:00pm PRA HEALTH SCIENCES INC : Annual General Meeting
05/31/18 | 03:00pm AGIOS PHARMACEUTICALS INC : Annual General Meeting
06/01/18 | 09:45pm BLUEBIRD BIO INC : American Society of Clinical Oncology Meeting - Abstract 8007
Past sector events for ALKERMES PLC
05/24/18 | 07:30pmNEUROCRINE BIOSCIENCES, INC. : Annual General Meeting
05/24/18 | 06:40pmNEKTAR THERAPEUTICS : Advances in Immuno-Oncology Congress
05/23/18 | 11:10pmIONIS PHARMACEUTICALS INC : Annual General Meeting
05/23/18 | 05:00pmEXELIXIS, INC. : Annual General Meeting
Annual results
Annual results20172018 (e)
Sales
Million $
Released
Forecast
Spread
903
874
3,4%

994
Operating income (EBITDA)
Million $
Released
Forecast
Spread
34,5
-75,0
146%

-41,1
Operating profit (EBIT)
Million $
Released
Forecast
Spread
34,5
-184
119%

-213
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-158
-166
5,1%

-219
EPS
 $
Released
Forecast
Spread
-1,03
-1,05
2,3%

-1,40
Announcement Date02/14/2018
Quarterly / Semiannualy publications
Quarterly resultsQ1
2018
Q2
2018 (e)
Sales
Million $
Released
Forecast
Spread
225
219
2,7%

247
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-22,2
-5,48
-305%

16,2
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-22,2
-75,9
71%

-48,7
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-62,5
-63,2
1,1%

-50,2
EPS
 $
Released
Forecast
Spread
-0,40
-0,41
1,5%

-0,33
Announcement Date04/26/2018
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise